Yoshifumi Shirakami

11PUBLICATIONS
25CO-AUTHORS
Molecular targetsAcceleratorsGene and molecular therapyPredictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 13, 2025
Astatine-211-Labeled Therapy Targeting Amino Acid Transporters: Overcoming Drug Resistance in Non-Small Cell Lung Cancer.

Sifan Feng, Kentaro Hisada, Haruna Yorifuji

|Nov 27, 2024
Development of LAT1-Selective Nuclear Medicine Therapeutics Using Astatine-211.

Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Kentaro Hisada

|Nov 27, 2024
Comparison Length of Linker in Compound for Nuclear Medicine Targeting Fibroblast Activation Protein as Molecular Target.

Kentaro Hisada, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami

|Nov 09, 2024
Evaluation of Targeted Alpha Therapy Using [211At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models.

Kaori Abe, Tadashi Watabe, Kazuko Kaneda-Nakashima

|Jun 19, 2024
Preclinical Evaluation of Biodistribution and Toxicity of [211At]PSMA-5 in Mice and Primates for the Targeted Alpha Therapy against Prostate Cancer.

Tadashi Watabe, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga

|Jan 23, 2024
Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides.

Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Yuichiro Kadonaga

Pageof 2

Frequent Collaborators

10 joint publications

Kazuko Kaneda-Nakashima

7 joint publications

Tadashi Watabe

6 joint publications

Koichi Fukase

4 joint publications

Jens Cardinale